Glen Tullman

Glen Tullman is the executive chairman of Transcarent and former CEO of Livongo (acquired by Teladoc for $18.5B), arguably the most consequential US digital health operator of the last two decades. His personal angel checks (separate from 7wireVentures, where he is a managing partner) cluster around digital health, healthcare software, and tech-enabled care delivery with an explicit AI lens, reflecting where Transcarent itself is going. Seed and Series A, $250k+ checks. Chicago-based, national reach. Best fit: founders building employer- or payer-facing care navigation, chronic condition management, or AI-enabled care orchestration, anything that rhymes with Livongo’s wedge of remote-monitoring-plus-coaching-plus-data, or with Transcarent’s care experience model. Hardware-first, biotech, or pure consumer wellness founders are off-pattern. Entry path is the 7wireVentures team (more scalable than Tullman’s personal inbox) or a warm intro through Livongo or Transcarent alumni; LinkedIn works but signal-to-noise is rough. He invests with strong opinions about employer health, member engagement, and the failed promise of pure-software disease management; come prepared to defend why your model actually changes outcomes and why employers will pay for it. If your answer is a portal, save your time.